Top articles of the week from The American Journal of Pharmacy Benefits.
AJPB staff
Advertisement
Articles by AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Lyrica extended-release tablets treat neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia.
Top articles of the week from The American Journal of Pharmacy Benefits.
Ingrezza is a selective VMAT2 inhibitor that was the first FDA-approved product indicated to treat adults with tardive dyskinesia.
Top articles of the week from The American Journal of Pharmacy Benefits.
OnabotulinumtoxinA is a prescription medication that works by injection into the muscles to treat frontalis muscle activity.
Top articles of the week from The American Journal of Pharmacy Benefits.
System involves a small sensor wire inserted below the skin’s surface to continuously measure and monitor glucose in adults with diabetes.
FDA states company sold unapproved and improperly labeled drugs that present serious public health risks, particularly sterile injectable skin whitening drug products.
Secnidazole (Solosec) oral granules granted approval to treat bacterial vaginosis in adult women.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top articles of the week from The American Journal of Pharmacy Benefits.
A look at the top stories in pharmacy last week.
Top articles of the week from The American Journal of Pharmacy Benefits.
Cymbalta is also indicated to treat general anxiety disorder in adults and children, fibromyalgia, or chronic muscle or joint pain, such as low back pain and osteoarthritis.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top articles of the week from The American Journal of Pharmacy Benefits.
A look at the top stories in pharmacy last week.
ASHP expresses concern over proposed cuts to Medicare payment rates for drugs that hospitals acquire under the 340B Drug Pricing Program.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top articles of the week from The American Journal of Pharmacy Benefits.
Top articles of the week from The American Journal of Pharmacy Benefits.
“National trends in prescription drug expenditures and projections for 2017,” highlights total US prescription sales for the 2016 calendar year.
Top articles of the week from The American Journal of Pharmacy Benefits.
Two-way text messaging system either maintained or improved A1C levels for teens with type 1 diabetes.
Top articles of the week from The American Journal of Pharmacy Benefits.
One in 11 Americans has diabetes today, and 86 million more – about one in three – are at risk for developing type 2 diabetes.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
4
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
5
